Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Briacell Therapeutics Corp (NQ: BCTX ) 0.8813 +0.1664 (+23.28%) Official Closing Price Updated: 4:15 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Briacell Therapeutics Corp < Previous 1 2 3 Next > Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase September 11, 2024 Via Benzinga Exposures Fossil Fuels Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge September 11, 2024 Via Benzinga Exposures Fossil Fuels Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday September 11, 2024 BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor. Via Benzinga Dow Tumbles 350 Points; US Inflation Rate Slows In August September 11, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024 June 14, 2024 BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. Via InvestorPlace BriaCell: An Emerging Immuno - Oncology Company August 14, 2023 BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer. Via Talk Markets Exposures Product Safety New Treatments May Help Those With Advanced Breast Cancer Live Longer April 17, 2023 Via StatePoint Media Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer February 08, 2023 A look at BriaCell's research into a better treatment for prostate cancer. Via Talk Markets Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 28, 2024 Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 21, 2024 Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning! Via InvestorPlace BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 March 19, 2024 BriaCell Therapeutics just reported results for the second quarter of 2024. Via InvestorPlace Get Rich Quick With These 3 Penny Stocks to Buy Now February 12, 2024 Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick. Via InvestorPlace Topics Economy Exposures Economy BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients December 20, 2023 BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients... Via Benzinga Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023 September 13, 2023 FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food... Via FinancialNewsMedia Exposures Product Safety BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 31, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 30, 2023 CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment Via TheNewswire.com BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily May 30, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer March 24, 2023 FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... Via FinancialNewsMedia BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers January 18, 2023 From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock... Via Talk Markets BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer January 18, 2023 Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach. Via Talk Markets BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 By Ernest Dela Aglanu, Benzinga Via News Direct Topics Death Exposures Death BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 14, 2022 Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... Via TheNewswire.com Topics Death Exposures Death BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients December 13, 2022 Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX< Via Benzinga BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 02, 2022 The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs... Via TheNewswire.com Topics Stocks Exposures Product Safety US Equities BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 02, 2022 By Faith Ashmore, Benzinga Via News Direct Exposures Product Safety BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 01, 2022 The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Via Benzinga IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies November 30, 2022 From ImmunoPrecise Antibodies Via Business Wire Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday September 20, 2022 Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. Via Benzinga Why Is BriaCell (BCTX) Stock Moving Today? April 13, 2022 BriaCell Therapeutics (BCTX) stock is on the move Wednesday morning after getting Fast Track approval from the FDA for Bria-IMT. Via InvestorPlace Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More April 13, 2022 Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.